- Home
- BODI vs RLYB Comparison
BODI vs RLYB Comparison
Compare BODI & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- RLYB
- Stock Information
- Founded
- BODI 1998
- RLYB 2018
- Country
- BODI United States
- RLYB United States
- Employees
- BODI N/A
- RLYB N/A
- Industry
- BODI Industrial Machinery/Components
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- RLYB Health Care
- Exchange
- BODI Nasdaq
- RLYB Nasdaq
- Market Cap
- BODI 38.8M
- RLYB 42.7M
- IPO Year
- BODI N/A
- RLYB 2021
- Fundamental
- Price
- BODI $6.51
- RLYB $0.88
- Analyst Decision
- BODI Strong Buy
- RLYB Buy
- Analyst Count
- BODI 3
- RLYB 6
- Target Price
- BODI $12.33
- RLYB $8.10
- AVG Volume (30 Days)
- BODI 17.4K
- RLYB 94.1K
- Earning Date
- BODI 03-10-2025
- RLYB 03-11-2025
- Dividend Yield
- BODI N/A
- RLYB N/A
- EPS Growth
- BODI N/A
- RLYB N/A
- EPS
- BODI N/A
- RLYB N/A
- Revenue
- BODI $451,432,000.00
- RLYB $598,000.00
- Revenue This Year
- BODI N/A
- RLYB N/A
- Revenue Next Year
- BODI N/A
- RLYB N/A
- P/E Ratio
- BODI N/A
- RLYB N/A
- Revenue Growth
- BODI N/A
- RLYB N/A
- 52 Week Low
- BODI $5.14
- RLYB $0.84
- 52 Week High
- BODI $12.13
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- BODI 51.94
- RLYB 37.61
- Support Level
- BODI $5.45
- RLYB $0.89
- Resistance Level
- BODI $7.50
- RLYB $0.95
- Average True Range (ATR)
- BODI 0.58
- RLYB 0.07
- MACD
- BODI 0.04
- RLYB -0.01
- Stochastic Oscillator
- BODI 51.71
- RLYB 4.74
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.